PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1513584
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1513584
Vascular Imaging Market Size - By Modality (Computed Tomography, MRI, Ultrasound, Nuclear Medicine, X-Ray), Application (Diagnostic, Therapeutic), Procedure (Coronary Angiography, Peripheral Angiography), End-use & Global Forecast, 2024 - 2032
Global Vascular Imaging Market size will expand at 5.9% CAGR from 2024 to 2032 due to increasing healthcare funding in emerging economies for supporting the development and adoption of advanced imaging technologies for diagnosing vascular conditions. Researchers and healthcare providers are exploring new techniques and enhancing existing modalities to improve diagnostic accuracy and patient outcomes.
The ongoing investments are also helping in integrating advanced technologies into routine medical practices to strengthen healthcare infrastructures and enhance accessibility to advanced diagnostic tools for vascular health. For instance, in October 2023, Abbott introduced its new vascular imaging platform powered by Ultreon 1.0 Software for enhancing the ability of physicians to visualize blood flow and identify coronary artery blockages.
The market is segregated into modality, application, procedure, end-use, and region.
In terms of modality, the ultrasound vascular imaging industry is set to experience significant growth rate through 2032 due to advancements for providing non-invasive insights into blood flow and vascular health. Ultrasound is widely used by healthcare professionals for diagnosing conditions, such as deep vein thrombosis and arterial stenosis. The increasing developments in ultrasound technology are further enhancing its capabilities for improving resolution and accuracy in vascular imaging.
By end-use, the vascular imaging market from the diagnostic imaging centres segment is projected to rise from 2024 to 2032, as these settings employ various techniques, such as ultrasound and MRI to assess blood flow and identify vascular abnormalities. These centers are enhancing their imaging technologies to improve diagnostic accuracy and patient care. They are also expanding their capabilities by integrating advanced imaging modalities for enabling more precise assessments of vascular health.
Regionally, the Asia Pacific vascular imaging industry size is projected to depict robust growth between 2024 and 2032, led by the surging government support and ongoing healthcare reforms. Several initiatives are supporting the adoption of advanced imaging technologies across healthcare facilities. There have been significant investments in infrastructure and training to enhance the accessibility and quality of vascular imaging services. Rising efforts for integrating advanced imaging modalities into routine medical practices for ensuring improved diagnostic capabilities and better patient outcomes across the region will favor the market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising prevalence of cancer and cardiac diseases
- 3.2.1.2 Technological advances and innovation in products
- 3.2.1.3 Growing awareness towards preventive healthcare and disease screening programs
- 3.2.1.4 Favorable government initiatives
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Increasing use of refurbished products
- 3.2.2.2 High cost associated with the products
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Company matrix analysis
- 4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Computed tomography
- 5.3 MRI
- 5.4 Ultrasound
- 5.5 Nuclear medicine
- 5.6 X-Ray
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Diagnostic
- 6.3 Therapeutic
Chapter 7 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Coronary angiography
- 7.3 Peripheral angiography
- 7.4 Neurovascular angiography
- 7.5 Vascular ultrasound
- 7.6 Microangiography
- 7.7 Cerebral angiography
- 7.8 Other procedures
Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Diagnostic imaging centers
- 8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Abbott Laboratories
- 10.2 Carestream Health
- 10.3 GE HealthCare Technologies Inc.
- 10.4 Hitachi, Ltd.
- 10.5 Hologic, Inc.
- 10.6 Koninklijke Philips N.V.
- 10.7 SAMSUNG ELECTRONICS Co., Ltd
- 10.8 Shimadzu Corporation
- 10.9 Siemens Healthineer AG
- 10.10 Terumo Corporation
